PanCAN welcomes Jon Mahrt, Chief Executive Officer of Optum Rx and Chief Growth Officer of Optum to the Board of Directors.

The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, ...

A new PanCAN-authored paper uses feedback provided by patients with pancreatic cancer to identify trends in reporting pain.

As part of our strategic approach to improve outcomes for pancreatic cancer patients, our Scientific and Medical Affairs team conducts independent and collaborative research. We disseminate important ...

Guiding the Pancreatic Cancer Community - Pancreatic Cancer Action Network*PanCAN’s Case Managers are not medical or nutritional professionals and are therefore unable to provide medical/nutritional ...

For the first time in more than 10 years, the FDA has approved a new first-line treatment, called NALIRIFOX, for patients with metastatic pancreatic cancer.

Home Research Strategic Research Program Learn Cell Signaling The Importance of Good Communication: Cell Signaling and How it Relates to Cancer In 2007, the United States Congress declared May as ...

Learn about the common symptoms of the world’s toughest cancer, such as weight loss, digestive problems, back pain and more.

American Cancer Society’s Cancer Facts & Figures 2023 reports that the five-year survival rate for pancreatic cancer has increased to 12%, progress that PanCAN’s initiatives helped to fuel.

Discover the five fruits recommended for pancreatic cancer patients by senior clinical dietitian at MD Anderson Cancer Center, Maria Petzel.